
Group leader: Charles Lawrie, Ph.D.
Biodonostia HRI. Ikerbasque Research Professor. charles.lawrie@biodonostia.orgStrategic Objectives
- To understand the molecular pathogenesis of haematological diseases (and other types of cancer) and the translation of that knowledge to clinical environments.
- To identify and develop new biomarkers for cancer diagnosis and prognosis.
Main lines of research
- The identification and assessment of the utility of circulating microRNA/RNA as non-invasive cancer biomarkers.
- Identification of factors behind drug resistance and new therapeutic procedures to treat cancer by using coding viral libraries for siRNA/microRNA.
- Identification of new mutations on the site of target gene-microRNA interaction and in the sequence of the same microRNA associated with cancer.
- Characterisation of the target miRNA:mRNA interface in cancer.
Team Members
Name Surname | Center | |
María Araiz Ramírez | Donostialdea IHO | maria.araizramirez@osakidetza.eus |
Angela Araujo | Biodonostia HRI | angela.araujo@biodonostia.org |
Maria Arestín Muruzabal | Biodonostia HRI | maria.arestin@biodonostia.org |
María Armesto Álvarez | Biodonostia HRI | maria.armesto@biodonostia.org |
Esther Arnaiz González | Biodonostia HRI | esther.arnaiz@biodonostia.org |
Laura Basterretxea Badiola | Donostialdea IHO | – |
Enrique Bengoechea Nerecan | Donostialdea IHO | – |
Izaskun Ceberio Echechipia | Donostialdea IHO | izaskun.ceberioechechipia@osakidetza.eus |
Giovanni Di Pinto | Biodonostia HRI | giovanni.dipinto@biodonostia.org |
Maitane Márquez López | Biodonostia HRI | maitane.marquez@biodonostia.org |
Carla Solé Cañadas | Biodonostia HRI | carla.sole@biodonostia.org |
Maitena Tellaeche Abete | Biodonostia HRI | maitena.tellaeche@biodonostia.org |
Scientific Output
